7.45
-0.45
(-5.70%)
At close: January 30 at 11:24:22 AM GMT+1
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
165,504.00
376,420.00
468,127.00
588,120.00
Total Liabilities Net Minority Interest
264,735.00
249,780.00
188,513.00
125,781.00
Total Equity Gross Minority Interest
-99,231.00
126,640.00
279,614.00
462,339.00
Total Capitalization
-99,231.00
126,640.00
279,614.00
462,339.00
Common Stock Equity
-99,231.00
126,640.00
279,614.00
462,339.00
Capital Lease Obligations
57,872.00
71,704.00
28,271.00
15,026.00
Net Tangible Assets
-99,231.00
126,640.00
279,614.00
462,339.00
Working Capital
-40,357.00
216,164.00
278,835.00
440,372.00
Invested Capital
-99,231.00
126,640.00
279,614.00
462,339.00
Tangible Book Value
-99,231.00
126,640.00
279,614.00
462,339.00
Total Debt
57,872.00
71,704.00
28,271.00
15,026.00
Share Issued
4,257.88
3,837.08
3,666.84
3,334.88
Ordinary Shares Number
4,257.88
3,837.08
3,666.84
3,334.88
12/31/2020 - 10/27/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
8AW0.BE Ocean Biomedical Inc
0.1810
-23.31%
0M4.DU Mersana Therapeutics Inc
0.5906
+2.64%
8AW0.F Ocean Biomedical, Inc.
0.2200
-34.91%
M55.F MacroGenics, Inc.
2.8940
-5.67%
2UV.F Applied Therapeutics, Inc.
0.5150
-2.00%
2UV.DU Applied Therapeutics Inc
0.5745
+2.96%
NV4.F Cellectar Biosciences, Inc.
0.2000
-9.91%
1VT.DU Viking Therapeutics Inc
32.15
-1.20%
3G0.BE Altimmune Inc
6.71
-0.52%
NV4.MU Cellectar Biosciences Inc
0.2420
-3.20%